Neuraminidase 1 secondary deficiency contributes to CNS pathology in neurological mucopolysaccharidoses via brain proteins hypersialylation

Journal:

Journal of Clinical Investigation

Published:

2025-06-17

DOI:

10.1172/jci177430

Affiliations:

14

Authors:

24

Go to article

Institutions	Authors	Share
McGill University, Canada	5.000000	0.21
CHU Sainte-Justine, Canada	4.000000	0.17
Institute for Polymers, Composites and Biomaterials (IPCB), CNR, Italy	3.000000	0.13
Hannover Medical School (MHH), Germany	3.000000	0.13
University of Alberta (U of A), Canada	2.000000	0.08
Institute of Pharmacology and Structural Biology (IPBS), France	2.000000	0.08
Nemours/Alfred I. duPont Hospital for Children, United States of America (USA)	2.000000	0.08
The University of Manchester (UoM), United Kingdom (UK)	1.000000	0.04
MRC Centre for Regenerative Medicine (CRM), The University of Edinburgh, United Kingdom (UK)	1.000000	0.04
Montreal Neurological Institute and Hospital (MNI), McGill University, Canada	1.000000	0.04

Interested in Medical Biochemistry and Metabolomics?